Menzel Garry E — SEC Form 4 filings

SEC reporting owner CIK 1556064. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-06-06 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Black Diamond Therapeutics, Inc. (BDTX)Director33
Stoke Therapeutics, Inc. (STOK)Director22
Adaptimmune Therapeutics PLC (ADAP)Director11

Form 4 filings — Menzel Garry E

FiledFormIssuerReported transactionsSource
2026-06-294Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-06-124Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 30,550 (derivative) @ $0EDGAR
2025-06-044Stoke Therapeutics, Inc. (STOK)Grant/award (A): 29,747 (derivative) @ $0EDGAR
2024-07-014Adaptimmune Therapeutics PLC (ADAP)Grant/award (A): 1,121,604 (derivative) @ $0EDGAR
2024-06-074Stoke Therapeutics, Inc. (STOK)Grant/award (A): 7,639 (derivative) @ $0EDGAR
2024-06-064Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 30,550 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1556064 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →